MDI/MDA dossier
More information on the MDI MDA dossier
SIEF communication
Based on pre-SIEF information from REACH-IT the Consortium has identified the need to communicate with multiple (> 1000 ) Legal Entity Contact Points or distinct email addresses.To ensure an efficient communication with such a large number of contacts and to comply with REACH transparency requirements, all Legal Entity Contact Points will be informed about the availability of all SIEF relevant information on this webpage and/or on REACH-IT :
- Lead registrant
- Substances list
- Data sharing
- Information on letters of access SIEF agreement
- End-uses covered by the registration dossier and the Chemical Safety Report
Substance Sameness
The sameness of the substances covered by this consortium was agreed and approved by the SIEF. All substances covered in this consortium have an agreed substance sameness specification (see REACH-IT).
Lead Registrant (LR)
All substances which have been registered in 2010 in this consortium have a confirmed LR.
Data sharing
The Consortium has available all the studies/data which are required. In case you would like to share your studies either as a registrant or as a data holder, please contact the Consortium Manager
End-uses covered by registration dossier
The end uses that are covered and used in the MDI registration dossiers have been identified and agreed between ISOPA** and the respective Downstream User Trade/Industry Associations.
End-uses and use descriptors for MDI substances can be found here.
End-uses and use descriptors for MDA substances